VGF, a new player in: Antidepressant action?

Jessica E. Malberg, Lisa M Monteggia

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Recent studies have identified adaptations of intracellular signaling pathways and target genes that could contribute or modulate the action of antidepressant drugs, as well as exercise-mediated antidepressant responses. Understanding these adaptations, particularly those changes that are common to diverse antidepressant treatments, is important for the development of more potent and specific treatments of depression. There is growing evidence that growth factors may be important mediators of antidepressant responses. Now, VGF (not an acronym), a neuropeptide that has previously been shown to be involved in maintaining organismal energy balance, as well as in mediating hippocampal synaptic plasticity, may be involved in mediating antidepressant responses. These studies use in vivo approaches to link VGF to the antidepressant- like behavioral effects produced by antidepressant drugs and exercise.

Original languageEnglish (US)
JournalScience Signaling
Volume1
Issue number18
DOIs
StatePublished - May 6 2008

Fingerprint

Antidepressive Agents
Neuronal Plasticity
Energy balance
Neuropeptides
Plasticity
Intercellular Signaling Peptides and Proteins
Genes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

VGF, a new player in : Antidepressant action? / Malberg, Jessica E.; Monteggia, Lisa M.

In: Science Signaling, Vol. 1, No. 18, 06.05.2008.

Research output: Contribution to journalArticle

Malberg, Jessica E. ; Monteggia, Lisa M. / VGF, a new player in : Antidepressant action?. In: Science Signaling. 2008 ; Vol. 1, No. 18.
@article{e34aefa89c2442f2b7a757a8329f205b,
title = "VGF, a new player in: Antidepressant action?",
abstract = "Recent studies have identified adaptations of intracellular signaling pathways and target genes that could contribute or modulate the action of antidepressant drugs, as well as exercise-mediated antidepressant responses. Understanding these adaptations, particularly those changes that are common to diverse antidepressant treatments, is important for the development of more potent and specific treatments of depression. There is growing evidence that growth factors may be important mediators of antidepressant responses. Now, VGF (not an acronym), a neuropeptide that has previously been shown to be involved in maintaining organismal energy balance, as well as in mediating hippocampal synaptic plasticity, may be involved in mediating antidepressant responses. These studies use in vivo approaches to link VGF to the antidepressant- like behavioral effects produced by antidepressant drugs and exercise.",
author = "Malberg, {Jessica E.} and Monteggia, {Lisa M}",
year = "2008",
month = "5",
day = "6",
doi = "10.1126/stke.118pe19",
language = "English (US)",
volume = "1",
journal = "Science Signaling",
issn = "1937-9145",
publisher = "American Association for the Advancement of Science",
number = "18",

}

TY - JOUR

T1 - VGF, a new player in

T2 - Antidepressant action?

AU - Malberg, Jessica E.

AU - Monteggia, Lisa M

PY - 2008/5/6

Y1 - 2008/5/6

N2 - Recent studies have identified adaptations of intracellular signaling pathways and target genes that could contribute or modulate the action of antidepressant drugs, as well as exercise-mediated antidepressant responses. Understanding these adaptations, particularly those changes that are common to diverse antidepressant treatments, is important for the development of more potent and specific treatments of depression. There is growing evidence that growth factors may be important mediators of antidepressant responses. Now, VGF (not an acronym), a neuropeptide that has previously been shown to be involved in maintaining organismal energy balance, as well as in mediating hippocampal synaptic plasticity, may be involved in mediating antidepressant responses. These studies use in vivo approaches to link VGF to the antidepressant- like behavioral effects produced by antidepressant drugs and exercise.

AB - Recent studies have identified adaptations of intracellular signaling pathways and target genes that could contribute or modulate the action of antidepressant drugs, as well as exercise-mediated antidepressant responses. Understanding these adaptations, particularly those changes that are common to diverse antidepressant treatments, is important for the development of more potent and specific treatments of depression. There is growing evidence that growth factors may be important mediators of antidepressant responses. Now, VGF (not an acronym), a neuropeptide that has previously been shown to be involved in maintaining organismal energy balance, as well as in mediating hippocampal synaptic plasticity, may be involved in mediating antidepressant responses. These studies use in vivo approaches to link VGF to the antidepressant- like behavioral effects produced by antidepressant drugs and exercise.

UR - http://www.scopus.com/inward/record.url?scp=48149112170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48149112170&partnerID=8YFLogxK

U2 - 10.1126/stke.118pe19

DO - 10.1126/stke.118pe19

M3 - Article

C2 - 18460680

AN - SCOPUS:48149112170

VL - 1

JO - Science Signaling

JF - Science Signaling

SN - 1937-9145

IS - 18

ER -